Not applicableUnknownNCT05658809What this trial is testingIntervention in Single Thyroid Nodule.Who this might be right forThyroid Nodule Assiut University 40
Not applicableLooking for participantsNCT06530316What this trial is testingRET Inhibitor for Neoadjuvant Therapy in Locally Advanced RET-altered Thyroid CancerWho this might be right forThyroid Cancer Fudan University 48
Not applicableUnknownNCT01700699What this trial is testingImpact of BRAFV600E Intratumor Heterogeneity in Thyroid Cancer Treated With Tyrosine Kinase InhibitorsWho this might be right forDifferentiated Thyroid Cancer University of Salerno 50
Not applicableNot Yet RecruitingNCT07071571What this trial is testingNew Intraoperative Nerve Monitoring DeviceWho this might be right forThryoid Cancerparathyrıoid Adenoma SB Istanbul Education and Research Hospital 40
Not applicableStudy completedNCT04072731What this trial is testingSREBP1 as a Potential Biomarker Promotes Cell Proliferation and Invasion in Thyroid CancerWho this might be right forThyroid Cancer People's Hospital of Zhengzhou University 140
Not applicableStudy completedNCT06292988What this trial is testingPredictive Factors for Medullary Thyroid Cancer AggressivenessWho this might be right forMedullary Thyroid Cancer Aristotle University Of Thessaloniki 500
Testing effectiveness (Phase 2)Ended earlyNCT05059470What this trial is testingIMRT Followed by Pembrolizumab in the Adjuvant Setting in Anaplastic Cancer of the Thyroid (IMPAACT): Phase II Trial Adjuvant Pembrolizumab After IMRT in ATCWho this might be right forThyroid M.D. Anderson Cancer Center 6
Not applicableStudy completedNCT00341094What this trial is testingScientific Protocol for the Study of Thyroid Cancer and Other Thyroid Disease in Ukraine Following the Chernobyl AccidentWho this might be right forThyroid CancerNon-Cancer Thyroid DiseaseNon Thyroid Cancer National Cancer Institute (NCI) 23,143
Testing effectiveness (Phase 2)Ended earlyNCT03787303What this trial is testingStudy of Euthyroid Hypothyroxinemia in Metastatic Breast CarcinomaWho this might be right forMetastatic Breast CancerThyroid Dysfunction Aultman Health Foundation 7
Early research (Phase 1)Study completedNCT00451880What this trial is testingStudy of XL281 in Adults With Solid TumorsWho this might be right forCancerNon-small-cell Lung CancerColorectal Cancer+2 more Exelixis 180
Not applicableStudy completedNCT01102127What this trial is testingElastography in Thyroid NodulesWho this might be right forNodular GoiterThyroid Cancer Castilla-León Health Service 128
Not applicableStudy completedNCT00454077What this trial is testingRhTSH-Thyroid Ablation With 1850 MBq of 131IWho this might be right forThyroid Cancer University of Siena 72
Not applicableStudy completedNCT05684029What this trial is testingNear-Infrared Autofluorescence With PTH Test Strip as an SOP of Parathyroid in Thyroid SurgeryWho this might be right forThyroid CancerHypoparathyroidismOptical Imaging Fujian Medical University 101
Not applicableLooking for participantsNCT07545837What this trial is testingHealth and Wellness Coaching to Improve Adherence to Healthy Habits and Treatment Plans in Papillary and Follicular Thyroid Cancer SurvivorsWho this might be right forThyroid Gland Follicular CarcinomaThyroid Gland Papillary Carcinoma Mayo Clinic 20
Early research (Phase 1)Study completedNCT00667641What this trial is testingPaclitaxel and Bortezomib in Treating Patients With Metastatic or Unresectable Malignant Solid TumorsWho this might be right forBreast CancerColorectal CancerHead and Neck Cancer+6 more University of Medicine and Dentistry of New Jersey 16
Testing effectiveness (Phase 2)Study completedNCT00381641What this trial is testingSunitinib Malate in Treating Patients With Thyroid Cancer That Did Not Respond to Iodine I 131 and Cannot Be Removed by SurgeryWho this might be right forDifferentiated Thyroid Gland CarcinomaRecurrent Thyroid Gland CarcinomaRefractory Thyroid Gland Carcinoma+16 more National Cancer Institute (NCI) 63
Early research (Phase 1)Ended earlyNCT02012231What this trial is testingPhase I/IIa Study to Evaluate the Safety, PK, PD, and Preliminary Efficacy of PLX8394 in Patients With Advanced Cancers.Who this might be right forMelanomaThyroid CancerColorectal Cancer+4 more Fore Biotherapeutics 5
Testing effectiveness (Phase 2)Active Not RecruitingNCT05119296What this trial is testingPhase II Trial of Pembrolizumab in Metastatic or Locally Advanced Anaplastic/Undifferentiated Thyroid CancerWho this might be right forThyroid Cancer Saad A Khan 9
Not applicableStudy completedNCT00316823What this trial is testingGenetic Analysis in Diagnosing Thyroid Cancer in Patients With Thyroid NodulesWho this might be right forHead and Neck Cancer University of California, San Francisco 400
Testing effectiveness (Phase 2)Study completedNCT03072160What this trial is testingPembrolizumab in Recurrent or Metastatic Medullary Thyroid CancerWho this might be right forMedullary Thyroid Cancer (MTC) National Cancer Institute (NCI) 17